Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens

Walmart

Walmart, CVS, and Walgreens must pay a combined $650.6 million to two Ohio counties for damages related to the opioid crisis, a federal judge ruled Wednesday.

Ohio judge rules Walmart, CVS, and Walgreens must pay a combined $650.6 million for damages related to opioid crisis

CLEVELAND — A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against national pharmacy chains CVS, Walgreens and Walmart, claiming the way they distributed opioids to customers caused severe harm to communities and created a public nuisance.

CVS, Walmart, Walgreens owe two Ohio counties $650 million in landmark opioid lawsuit

CVS, Walgreens and Walmart must pay damages to two Ohio counties for oversupplying pills that ended up on black market

US pharmacies ordered to pay $650.6m for role in opioids crisis

43 percent of Americans say they'll visit a retail pharmacy to get the flu vaccine this season CVS.com and the CVS Pharmacy app allow families to schedule multiple appointments at once, providing added convenience WOONSOCKET, R.I. , Aug. 16, 2022 /PRNewswire/ -- CVS Health® (NYSE: CVS) is reminding Americans that it is more important than ever to stay current with vaccinations and other routine health care needs.

Flu shots now available at CVS Pharmacy® and MinuteClinic® nationwide

CVS Health stock (NYSE: CVS) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.

What's Next For CVS Health Stock After An Upbeat Q2?

A lot will come down to how much you invest in the business, and what kind of return you should expect from the stock.

Could CVS Health Stock Help You Become a Millionaire?

Here is how CVS Health (CVS) and Dollar Tree (DLTR) have performed compared to their sector so far this year.

Has CVS Health (CVS) Outpaced Other Retail-Wholesale Stocks This Year?

New safes for controlled substances anticipated to help reduce organized retail crime All 106 CVS Pharmacy® locations across Colorado, Utah, Montana, Idaho and Wyoming now using time delay safe technology WOONSOCKET, R.I. , Aug. 10, 2022 /PRNewswire/ -- As part of an ongoing commitment to support law enforcement and help build safer communities, CVS Health® (NYSE: CVS) today announced the installation of time delay safe technology in all 106 CVS Pharmacy locations, including those in Target stores, across five states in the western U.S. The states and corresponding number of pharmacy locations include Colorado (54), Utah (30), Montana (15), Idaho (4) and Wyoming (3).

CVS Health completes rollout of time delay safes in five western states

Additional funding brings Series D round to $320M total Trevor Fetter, MBA, senior lecturer on the faculty of Harvard Business School and former longtime Tenet Healthcare chairman and CEO, named to Board Sachin H. Jain, physician executive with government, pharmaceutical, payer and provider experience, joins Board BOSTON , Aug. 10, 2022 /PRNewswire/ -- Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M.

Biofourmis Raises Additional Funding from Intel Capital in Series D Extension and Names Top Healthcare Leaders to its Board

Not only reported CVS's strong quarterly results, but the company will also generate about $40-50 billion in cash flow in the next three years. CVS will be able to repay debt in the next few years, increase the dividend, and still have cash left for share buybacks.

CVS Health: Still Undervalued And Resilient To A Recession

Increasing revenue and the favourably updated guidance indicates the demand for CVS's products and services remain high. Despite the uncertain macroeconomic environment, we expect CVS to perform well in the near term as the demand for their products/services is relatively inelastic and their FX risk is low.

3 Reasons Why We Like CVS After The Earnings Report

In this article will analyze the current, and future, outlook for CVS and WBA stocks and explain why each has a case to make for different investors.

CVS and Walgreens Show Why Investment Objectives Matter

Signify Health

A fresh report cites sources stating that CVS Health (NYSE: CVS ) is interested in buying out Signify Health (NYSE: SGFY ). Neither of these two companies has confirmed the takeover interest, as of this writing.

Signify Health (SGFY) Stock Jumps 15% on CVS Takeover Rumors

CVS is reportedly looking to purchase healthcare platform Signify Health, which would allow the drugstore chain to expand into home health services. Signify has been exploring “strategic alternatives,” which could include a sale, according to a report from the Wall Street Journal Sunday (Aug. 7) that cited unnamed sources.

CVS Reportedly Eyeing Signify Health to Expand Into Medical Services

CVS Health Corp. is seeking to buy Signify Health Inc., according to people familiar with the matter, as the drugstore and insurance giant looks to expand in home-health services.

CVS seeking to buy Signify Health as part of home-health expansion

CVS Health Corp is planning to buy Signify Health Inc as it looks to expand in home-health services, the Wall Street Journal reported on Sunday, citing sources.

CVS Health plans to buy Signify Health - WSJ

Amwell is driving ahead with its vision of becoming a platform of platforms with its Converge initiative with clients — most notably CVS Health — as the company moves aggressively to become a dominant player in the space in what it called a “transitional time.” On a second quarter earnings call on Thursday (Aug.

Amwell Announces Pact to Power CVS Virtual Care Offering During Q2 Call

CVS Health CEO Karen Lynch said Wednesday the pharmacy chain plans to take action to acquire or merge with a primary care firm by the end of the year.

CVS plans to make a move into primary care by end of 2022

Certain types of investors will find a lot to like with CVS Health.

CVS Health Is Beating the Market: Is the Stock a Buy?

CVS said it would either purchase or take a stake in a primary-care company before the year is over, part of a wave of pharmacy retailers strengthening their medical care offerings. As CNBC reported Wednesday (Aug.

CVS Moves Closer to Offering Primary Healthcare

CVS has exceeded its Q2 expectations with the help of COVID test kit sales and a growing number of prescriptions. The longer cold season has helped the company thrive.

CVS exceeds Q2 expectations thanks to growing prescriptions, COVID test kits

CVS Health (CVS) posts better-than-expected results in Q2, with robust performances across all operating segments driving the top line.

CVS Health (CVS) Q2 Earnings Beat Estimates, Margins Down

CVS Health plans to grow its business of selling individual coverage under the Affordable Care Act for 2023 to four new states.

CVS Health Will Expand Obamacare Offerings To 12 States

CVS Health Corporation (NYSE:CVS ) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Larry McGrath - Senior Vice President Business Development and Investor Relations | Karen Lynch - President and Chief Executive Officer Shawn Guertin - Executive Vice President and Chief Financial Officer Alan Lotvin - President, Pharmacy Services Dan Finke - President, Healthcare Benefits Michelle Peluso - Executive Vice President. Chief Customer Officer and Co-President, Retail Prem Shah - Executive Vice President, Chief Pharmacy Officer and Co-President, Retail Tom Cowhey - Senior Vice President, Capital Markets Conference Call Participants Ricky Goldwasser - Morgan Stanley Lisa Gill - JPMorgan A.J.

CVS Health Corporation (CVS) CEO Karen Lynch on Q2 2022 Results - Earnings Call Transcript

Aetna CVS Health Individual and Family Plans combine the quality health insurance coverage of Aetna®, with affordable care options at CVS Pharmacy® and MinuteClinic® locations to help members achieve their best health. WOONSOCKET, R.I.

News for CVS Health Stock (CVS)